HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/3/G779    most recent 00470.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Foley, K. F. Articles by Mawe, G. M. Search for Related Content PubMed PubMed Citation Articles by Foley, K. F. Articles by Mawe, G. M.

INFLAMMATION/IMMUNITY/MEDIATORS

IFN- and TNF- decrease serotonin transporter function and expression in Caco2 cells

¹Department of Medical Laboratory and Radiation Sciences and ²Department of Anatomy and Neurobiology, the University of Vermont; and ³Department of Pathology, Fletcher Allen Health Care, Burlington, Vermont

Submitted 11 October 2006 ; accepted in final form 7 December 2006

Recent studies have shown that mucosal serotonin (5-HT) transporter (SERT) expression is decreased in animal models of colitis, as well as in the colonic mucosa of humans with ulcerative colitis and irritable bowel syndrome. Altered SERT function or expression may underlie the altered motility, secretion, and sensation seen in these inflammatory gut disorders. In an effort to elucidate possible mediators of SERT downregulation, we treated cultured colonic epithelial cells (Caco2) with conditioned medium from activated human lymphocytes. Application of the conditioned medium caused a decrease in fluoxetine-sensitive [³H]5-HT uptake. Individual proinflammatory agents were then tested for their ability to affect uptake. Cells were treated for 48 or 72 h with PGE₂ (10 µM), IFN- (500 ng/ml), TNF- (50 ng/ml), IL-12 (50 ng/ml), or the nitric oxide-releasing agent S-nitrosoglutathione (GSNO; 100 µM). [³H]5-HT uptake was then measured. Neither PGE nor IL-12 had any effect on [³H]5-HT uptake, and GSNO increased uptake. However, after 3-day incubation, both TNF- and IFN- elicited significant decreases in SERT function. Neither TNF- nor IFN- were cytotoxic when used for this period of time and at these concentrations. These two cytokines also induced decreases in SERT mRNA and protein levels. By altering SERT expression, TNF- and IFN- could contribute to the altered motility and expression seen in vivo in ulcerative colitis or irritable bowel syndrome.

SERT; tumor necrosis factor; interferon; colitis; inflammatory bowel disease; inflammation

This article has been cited by other articles:

				K. A. Wojtal, J. J. Eloranta, P. Hruz, H. Gutmann, J. Drewe, A. Staumann, C. Beglinger, M. Fried, G. A. Kullak-Ublick, and S. R. Vavricka Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients Drug Metab. Dispos., September 1, 2009; 37(9): 1871 - 1877. [Abstract] [Full Text] [PDF]

				S. C. Bischoff, R. Mailer, O. Pabst, G. Weier, W. Sedlik, Z. Li, J. J. Chen, D. L. Murphy, and M. D. Gershon Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G685 - G695. [Abstract] [Full Text] [PDF]

				W. A. Alrefai, X. Wen, W. Jiang, J. P. Katz, K. A. Steinbrecher, M. B. Cohen, I. R. Williams, P. K. Dudeja, and G. D. Wu Molecular cloning and promoter analysis of downregulated in adenoma (DRA) Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G923 - G934. [Abstract] [Full Text] [PDF]